Post-operative Analgesic Effects of Dexamethasone Added to Bupivacaine in Transversusabdominis Plane (TAP) Block

NCT ID: NCT03863977

Last Updated: 2020-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2/PHASE3

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-15

Study Completion Date

2020-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the postoperative analgesic effect of two doses of dexamethasone added to bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The transverses abdominis plane block (TAP block) is a regional anesthesia technique that provides analgesia following abdominal surgery . The TAP block significantly reduces pain after open inguinal hernia repair, regardless of whether it is used as a primary anesthesia technique or as a complement to general anesthesia, spinal or local anesthesia .

The investigators designed this study to compare the postoperative analgesic effect of two doses of dexamethasone( 4 mg and 8 mg ) added to bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

60 patients will be divided into two groups according to the dose of dexamethasone added to bupivacaine in the TAP block, I - group ( Group D4 ) 4mg of dexamethasone will be added II - group ( Group D8 ) 8mg of dexamethasone will be added. III-group(control) bupivacaine alone
Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors
A blinded physician prepared the study medications in color coded syringes.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dex4 group

After the surgery, the patients in this group will receive 4 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Group Type ACTIVE_COMPARATOR

Dexamethasone

Intervention Type DRUG

After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Bupivacaine

Intervention Type DRUG

After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.

Dex8 group

After the surgery, the patients in this group will receive 8 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Group Type ACTIVE_COMPARATOR

Dexamethasone

Intervention Type DRUG

After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Bupivacaine

Intervention Type DRUG

After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.

control group

After the surgery, the patients in this group will 1mg/kg of 0.5% bupivacaine in the TAP block.

Group Type ACTIVE_COMPARATOR

Bupivacaine

Intervention Type DRUG

After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexamethasone

After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention Type DRUG

Bupivacaine

After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

dexamethasone acetate plain marcaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients' age from 18 to 60 years old,
* physical status ASA I-II (by the American Society of Anesthesiologists),
* Elective unilateral open inguinal hernia repair,
* Under spinal anesthesia

Exclusion Criteria

* age \< 18 or \> 60,
* American society of anesthesiologist (ASA)class III-IV,
* known allergy to amino amide local anesthetics,
* skin infection and diseases at site of injection.
* coagulation disorders,
* patients with body mass index (BMI) \> 35 kg/m2,
* scrotal hernias,
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amani Hassan Abdel-Wahab

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amany Hassan, Lectural

Role: PRINCIPAL_INVESTIGATOR

Assiut university, Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assiut university hospitals

Asyut, Assiut Governorate, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB:17100670

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexamethasone Versus Dexmedetomidine
NCT03064633 COMPLETED PHASE4
Dexmedetomidine in Postoperative Analgesia
NCT05705128 ENROLLING_BY_INVITATION PHASE2/PHASE3